175 related articles for article (PubMed ID: 33037737)
1. Efficacy of the novel tubulin polymerization inhibitor PTC-028 for myelodysplastic syndrome.
Zhong C; Kayamori K; Koide S; Shinoda D; Oshima M; Nakajima-Takagi Y; Nagai Y; Mimura N; Sakaida E; Yamazaki S; Iwano S; Miyawaki A; Ito R; Tohyama K; Yamaguchi K; Furukawa Y; Lennox W; Sheedy J; Weetall M; Iwama A
Cancer Sci; 2020 Dec; 111(12):4336-4347. PubMed ID: 33037737
[TBL] [Abstract][Full Text] [Related]
2. The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells.
Nagai Y; Mimura N; Rizq O; Isshiki Y; Oshima M; Rizk M; Saraya A; Koide S; Nakajima-Takagi Y; Miyota M; Chiba T; Oshima-Hasegawa N; Muto T; Tsukamoto S; Mitsukawa S; Takeda Y; Ohwada C; Takeuchi M; Iseki T; Nakaseko C; Lennox W; Sheedy J; Weetall M; Yokote K; Iwama A; Sakaida E
Sci Rep; 2021 Jan; 11(1):2074. PubMed ID: 33483574
[TBL] [Abstract][Full Text] [Related]
3. DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes.
Kayamori K; Nagai Y; Zhong C; Kaito S; Shinoda D; Koide S; Kuribayashi W; Oshima M; Nakajima-Takagi Y; Yamashita M; Mimura N; Becker HJ; Izawa K; Yamazaki S; Iwano S; Miyawaki A; Ito R; Tohyama K; Lennox W; Sheedy J; Weetall M; Sakaida E; Yokote K; Iwama A
Blood Adv; 2021 Jan; 5(2):438-450. PubMed ID: 33496740
[TBL] [Abstract][Full Text] [Related]
4. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
[TBL] [Abstract][Full Text] [Related]
5. Rigosertib induces cell death of a myelodysplastic syndrome-derived cell line by DNA damage-induced G2/M arrest.
Hyoda T; Tsujioka T; Nakahara T; Suemori S; Okamoto S; Kataoka M; Tohyama K
Cancer Sci; 2015 Mar; 106(3):287-93. PubMed ID: 25580850
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent.
Jernigan F; Branstrom A; Baird JD; Cao L; Dali M; Furia B; Kim MJ; O'Keefe K; Kong R; Laskin OL; Colacino JM; Pykett M; Mollin A; Sheedy J; Dumble M; Moon YC; Sheridan R; Mühlethaler T; Spiegel RJ; Prota AE; Steinmetz MO; Weetall M
Mol Cancer Ther; 2021 Oct; 20(10):1846-1857. PubMed ID: 34315764
[TBL] [Abstract][Full Text] [Related]
7. AICAR suppresses cell proliferation and synergizes with decitabine in myelodysplastic syndrome via DNA damage induction.
Liu J; Liang L; Li X; Peng YL; Zhang J; Wang XL; Liu J; Nie L
Biotechnol Lett; 2021 Jun; 43(6):1131-1142. PubMed ID: 33788127
[TBL] [Abstract][Full Text] [Related]
8. Novel Benzo[B]Furans with Anti-Microtubule Activity Upregulate Expression of Apoptotic Genes and Arrest Leukemia Cells in G2/M Phase.
Królewska-Golińska K; Cieślak MJ; Sobczak M; Dolot R; Radzikowska-Cieciura E; Napiórkowska M; Wybrańska I; Nawrot B
Anticancer Agents Med Chem; 2019; 19(3):375-388. PubMed ID: 30465514
[TBL] [Abstract][Full Text] [Related]
9. Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma.
Xiang Q; Zhen Z; Deng DY; Wang J; Chen Y; Li J; Zhang Y; Wang F; Chen N; Chen H; Chen Y
J Exp Clin Cancer Res; 2015 Oct; 34():118. PubMed ID: 26458953
[TBL] [Abstract][Full Text] [Related]
10. Decitabine shows synergistic effects with arsenic trioxide against myelodysplastic syndrome cells via endoplasmic reticulum stress-related apoptosis.
Huang L; Liu Z; Jiang H; Li L; Fu R
J Investig Med; 2019 Oct; 67(7):1067-1075. PubMed ID: 30898879
[TBL] [Abstract][Full Text] [Related]
11. MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2/M arrest in nonresistant and paclitaxel-resistant cancer cells.
Lee WH; Liu HE; Chang JY; Liou JP; Huang HM
Pharmacology; 2013; 92(1-2):90-8. PubMed ID: 23949011
[TBL] [Abstract][Full Text] [Related]
12. (4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone inhibits tubulin polymerization, induces G2/M arrest, and triggers apoptosis in human leukemia HL-60 cells.
Magalhães HI; Wilke DV; Bezerra DP; Cavalcanti BC; Rotta R; de Lima DP; Beatriz A; Moraes MO; Diniz-Filho J; Pessoa C
Toxicol Appl Pharmacol; 2013 Oct; 272(1):117-26. PubMed ID: 23756174
[TBL] [Abstract][Full Text] [Related]
13. Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials.
Yun S; Vincelette ND; Abraham I; Robertson KD; Fernandez-Zapico ME; Patnaik MM
Clin Epigenetics; 2016; 8():68. PubMed ID: 27307795
[TBL] [Abstract][Full Text] [Related]
14. Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update.
Joeckel TE; Lübbert M
Semin Hematol; 2012 Oct; 49(4):330-41. PubMed ID: 23079063
[TBL] [Abstract][Full Text] [Related]
15. Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine.
Duong VH; Bhatnagar B; Zandberg DP; Vannorsdall EJ; Tidwell ML; Chen Q; Baer MR
Leuk Lymphoma; 2015 Jun; 56(6):1718-22. PubMed ID: 25263320
[TBL] [Abstract][Full Text] [Related]
16. Estradiol dimer inhibits tubulin polymerization and microtubule dynamics.
Jurášek M; Černohorská M; Řehulka J; Spiwok V; Sulimenko T; Dráberová E; Darmostuk M; Gurská S; Frydrych I; Buriánová R; Ruml T; Hajdúch M; Bartůněk P; Dráber P; Džubák P; Drašar PB; Sedlák D
J Steroid Biochem Mol Biol; 2018 Oct; 183():68-79. PubMed ID: 29803726
[TBL] [Abstract][Full Text] [Related]
17. MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
Wang CC; Liu HE; Lee YL; Huang YW; Chen YJ; Liou JP; Huang HM
Tumour Biol; 2016 May; 37(5):6065-72. PubMed ID: 26608370
[TBL] [Abstract][Full Text] [Related]
18. Comparison between decitabine and azacitidine for the treatment of myelodysplastic syndrome: a meta-analysis with 1,392 participants.
Xie M; Jiang Q; Xie Y
Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):22-8. PubMed ID: 25042977
[TBL] [Abstract][Full Text] [Related]
19. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.
Kimura S; Kuramoto K; Homan J; Naruoka H; Ego T; Nogawa M; Sugahara S; Naito H
Anticancer Res; 2012 Mar; 32(3):795-8. PubMed ID: 22399596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
